RenovoRx, Inc.

US$1.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RNXTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (34.30%)
Div yield —
ROE (149.98%)
Biotechnology
Beta (5Y) 1.17
PE TTM —
TSR TTM 1.80%
Mkt cap US$51.00M
ROIC (91.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.25
10.93%
223.18%
Hold 7|10|8|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
15.10%
9.96%
5.01%
7.70%
Revenue$M
2.433
2.528
2.476
2.623
2.89%
8.65%
2.90%
10.56%
Peers (US$51.00M)
Cap (US$)
PE
50.25M
—
Capital
TTM
5Y
10Y
Leveragex
0.843
0.376
0.375
EBIT/Intx
0.814
0.278
0.254
Own earn%
36.66
20.02
18.67
Sh yield%
27.52
46.50
47.00
Owners
Insiders/Inst%
7.44
56.59
Short interest%
5.39
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
7–13
$1 testx
0.5
Incr. ROIC%
1